Atlas Trials

Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia

Clinical trial NCT05169268 · COMPLETED

Trial details

NCT number
NCT05169268
Sponsor
The University of Hong Kong
Status
COMPLETED
Study type
OBSERVATIONAL
Schizophrenia and Related DisordersAnxiety Depression
Start date
2022-02-01
Primary completion
2026-01-31
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.